申请人:Portola Pharmaceuticals, Inc.
公开号:US20190119236A1
公开(公告)日:2019-04-25
The present disclosure relates to novel compounds, methods, and compositions capable of binding to PCSK9, thereby modulating PCSK9 proprotein convertase enzyme activity. The compounds of the disclosure include compounds Formula (I).